- Home
- RADX vs FCUV Comparison
RADX vs FCUV Comparison
Compare RADX & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- FCUV
- Stock Information
- Founded
- RADX 2021
- FCUV 2012
- Country
- RADX Australia
- FCUV United States
- Employees
- RADX N/A
- FCUV N/A
- Industry
- RADX
- FCUV Industrial Machinery/Components
- Sector
- RADX
- FCUV Industrials
- Exchange
- RADX NYSE
- FCUV Nasdaq
- Market Cap
- RADX 32.5M
- FCUV 27.6M
- IPO Year
- RADX N/A
- FCUV N/A
- Fundamental
- Price
- RADX $4.20
- FCUV $3.87
- Analyst Decision
- RADX Strong Buy
- FCUV
- Analyst Count
- RADX 2
- FCUV 0
- Target Price
- RADX $13.50
- FCUV N/A
- AVG Volume (30 Days)
- RADX 18.6K
- FCUV 13.9K
- Earning Date
- RADX 02-26-2025
- FCUV 08-13-2025
- Dividend Yield
- RADX N/A
- FCUV N/A
- EPS Growth
- RADX N/A
- FCUV N/A
- EPS
- RADX N/A
- FCUV N/A
- Revenue
- RADX $204,609.00
- FCUV $408,887.00
- Revenue This Year
- RADX N/A
- FCUV N/A
- Revenue Next Year
- RADX N/A
- FCUV N/A
- P/E Ratio
- RADX N/A
- FCUV N/A
- Revenue Growth
- RADX N/A
- FCUV 6.49
- 52 Week Low
- RADX $3.50
- FCUV $1.50
- 52 Week High
- RADX $50.82
- FCUV $10.90
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- FCUV 44.51
- Support Level
- RADX N/A
- FCUV $3.73
- Resistance Level
- RADX N/A
- FCUV $4.05
- Average True Range (ATR)
- RADX 0.00
- FCUV 0.21
- MACD
- RADX 0.00
- FCUV -0.00
- Stochastic Oscillator
- RADX 0.00
- FCUV 23.73
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.